ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Sonendo Announces EndoCon 2023, An Endodontic Conference on Practice Growth

The Event Will Offer Lectures, Workshops and Training Sessions for Clinicians, Staff and Postgrad Residents

Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced its third EndoCon, a comprehensive program covering the latest in endodontic technology and innovation. Taking place in San Diego at the Manchester Grand Hyatt from Oct. 5-7, the three-day event will offer lectures, workshops and training sessions for clinicians, staff and postgrad residents.

Offering something for everyone, EndoCon will give endodontists and their teams access to decades worth of experience and knowledge from master clinicians and endodontic thought leaders. The schedule is comprised of world-class clinical and practice management lectures, continuing education sessions and hands-on learning opportunities. The scientific, expert and keynote continuing education sessions will focus on compelling and forward-looking topics including growth mindset – the art and science of success, artificial intelligence (AI) in medical imaging, leveraging AI for business success, and modern AI pathology platform solutions.

"We remain committed to driving innovation and excellence in endodontics and supporting industry professionals as best we can,” said Michael Smith, chief commercial officer at Sonendo. “EndoCon embodies our dedication to advancing the field and providing clinicians and their teams with the tools and knowledge they need to succeed and, most importantly, deliver exceptional patient care."

Additionally, the event provides an opportunity for attendees to network and socialize, with special events spanning a welcome reception, resident and program director luncheon and Women in Endodontics luncheon. The complete schedule can be viewed here.

EndoCon attendees will also learn more about how the GentleWave System can support practice growth, streamline workflows and enhance overall patient care. For additional information on EndoCon, visit here.

For more information on the GentleWave System, visit https://gentlewave.com/doctor/.

About Sonendo

Sonendo is a commercial-stage medical technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of the GentleWave System when compared to conventional methods of root canal therapy include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices. Sonendo is also the parent company of TDO Software, the developer of widely used endodontic practice management software solutions, designed to simplify practice workflow. TDO Software integrates practice management, imaging, referral reporting and CBCT imaging, and offers built-in communication with the GentleWave System.

For more information on Sonendo, visit www.sonendo.com. For more information on the GentleWave System, visit www.gentlewave.com/doctor.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.